Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05173233

Confirmatory Clinical Study of Treating Tricuspid Regurgitation With K-Clip TM Transcatheter Annuloplasty System

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
67 (estimated)
Sponsor
Shanghai Huihe Medical Technology Co., Ltd · Industry
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The present clinical trial is performed to evaluate the effectiveness and safety of transcatheter tricuspid annuloplasty system manufactured by Shanghai Huihe Healthcare technology Co.,Ltd. for the treatment of subjects with severe or worse tricuspid regurgitation.

Conditions

Interventions

TypeNameDescription
DEVICETranscatheter AnnuloplastyUnder echocardiography guidance, the transcatheter tricuspid annuloplasty system precisely reaches the specified position in the tricuspid valve region via jugular vein and superior vena cava approach. The enlarged tricuspid annular tissue is clamped with the clamp cpart and anchor part to reduce the perimeter of tricuspid annulus, so that the area of tricuspid orifice that could not be coapted is reduced. It plays the purpose of minimally invasive treatment of tricuspid valve.

Timeline

Start date
2022-05-15
Primary completion
2023-05-15
Completion
2027-05-15
First posted
2021-12-29
Last updated
2022-04-21

Source: ClinicalTrials.gov record NCT05173233. Inclusion in this directory is not an endorsement.